Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Harvey Jay Mamon, M.D., Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Yang TS, Wang XF, Fairweather M, Sun YH, Mamon HJ, Wang JP. The Survival Benefit From the Addition of Radiation to Chemotherapy in Gastric Cancer Patients Following Surgical Resection. Clin Oncol (R Coll Radiol). 2020 Feb; 32(2):110-120. PMID: 31570246.
    Citations:    
  2. Mitra D, Horick NK, Brackett DG, Mouw KW, Hornick JL, Ferrone S, Hong TS, Mamon H, Clark JW, Parikh AR, Allen JN, Ryan DP, Ting DT, Deshpande V, Wo JY. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy. Oncologist. 2019 06; 24(6):e275-e283. PMID: 30755500.
    Citations:    
  3. Schrag D, Weiser M, Saltz L, Mamon H, Gollub M, Basch E, Venook A, Shi Q. Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance). Clin Trials. 2019 04; 16(2):165-175. PMID: 30688523.
    Citations:    Fields:    
  4. Muralidhar V, Nipp RD, Mamon HJ, Punglia RS, Hong TS, Ferrone C, Fernandez-Del Castillo C, Parikh A, Nguyen PL, Wo JY. Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer. Ann Surg Oncol. 2018 Dec; 25(13):4027-4034. PMID: 30298331.
    Citations:    Fields:    
  5. Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM, Wind JK, Shaw MC, Heon N, Shi Q, Ginos B, Nelson GD, Meyers JP, Chang GJ, Mamon HJ, Weiser MR, Kolevska T, Reeve BB, Bruner DW, Schrag D. Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048. J Clin Oncol. 2018 Sep 11; JCO2018788620. PMID: 30204536.
    Citations:    Fields:    
  6. Ladas I, Yu F, Leong KW, Fitarelli-Kiehl M, Song C, Ashtaputre R, Kulke M, Mamon H, Makrigiorgos GM. Enhanced detection of microsatellite instability using pre-PCR elimination of wild-type DNA homo-polymers in tissue and liquid biopsies. Nucleic Acids Res. 2018 07 06; 46(12):e74. PMID: 29635638.
    Citations:    Fields:    
  7. Gerbaudo VH, Killoran JH, Kim CK, Hornick JL, Nowak JA, Enzinger PC, Mamon HJ. Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response. Ann Nucl Med. 2018 Apr; 32(3):165-174. PMID: 29332233.
    Citations:    Fields:    Translation:Humans
  8. Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Ye X, Swanson RS, Enzinger PC, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, Ciombor K, Berg DJ, Meyerhardt J, Mayer RJ. Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). J Clin Oncol. 2017 Nov 10; 35(32):3671-3677. PMID: 28976791.
    Citations: 5     Fields:    Translation:Humans
  9. Pretz JL, Blake MA, Killoran JH, Mamon HJ, Wo JY, Zhu AX, Hong TS. Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer. Pract Radiat Oncol. 2018 May - Jun; 8(3):179-184. PMID: 29042120.
    Citations:    Fields:    Translation:Humans
  10. Gilbert JW, Wolpin B, Clancy T, Wang J, Mamon H, Shinagare AB, Jagannathan J, Rosenthal M. Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al. Ann Oncol. 2017 09 01; 28(9):2316. PMID: 28541392.
    Citations:    Fields:    Translation:Humans
  11. Hong TS, Wo JY, Borger DR, Yeap BY, McDonnell EI, Willers H, Blaszkowsky LS, Kwak EL, Allen JN, Clark JW, Tanguturi S, Goyal L, Murphy JE, Wolfgang JA, Drapek LC, Arellano RS, Mamon HJ, Mullen JT, Tanabe KK, Ferrone CR, Ryan DP, Iafrate AJ, DeLaney TF, Zhu AX. Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype. J Natl Cancer Inst. 2017 09 01; 109(9). PMID: 28954285.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  12. Gilbert JW, Wolpin B, Clancy T, Wang J, Mamon H, Shinagare AB, Jagannathan J, Rosenthal M. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification. Ann Oncol. 2017 Sep 01; 28(9):2067-2076. PMID: 28407088.
    Citations: 4     Fields:    Translation:Humans
  13. Mihalcik SA, Virani S, Hong TS, Niemierko A, Mino-Kenudson M, Kobayashi WK, Fernández-Del Castillo C, Mamon HJ. Assessment of the Utility of Laparoscopy and Peritoneal Cytology in the Staging of Pancreatic Cancer. Pancreas. 2017 08; 46(7):e60-e62. PMID: 28697144.
    Citations:    Fields:    Translation:Humans
  14. Sanford NN, Catalano PJ, Enzinger PC, King BL, Bueno R, Martin NE, Hong TS, Wo JY, Mamon HJ. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer. Dis Esophagus. 2017 Jul 01; 30(7):1-8. PMID: 28475728.
    Citations: 3     Fields:    Translation:Humans
  15. Zerillo JA, Schouwenburg MG, van Bommel ACM, Stowell C, Lippa J, Bauer D, Berger AM, Boland G, Borras JM, Buss MK, Cima R, Van Cutsem E, van Duyn EB, Finlayson SRG, Hung-Chun Cheng S, Langelotz C, Lloyd J, Lynch AC, Mamon HJ, McAllister PK, Minsky BD, Ngeow J, Abu Hassan MR, Ryan K, Shankaran V, Upton MP, Zalcberg J, van de Velde CJ, Tollenaar R. An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer. JAMA Oncol. 2017 May 01; 3(5):686-694. PMID: 28384684.
    Citations: 2     Fields:    Translation:Humans
  16. Rose BS, Winer EP, Mamon HJ. Reply to S. Sorscher. J Clin Oncol. 2017 05 20; 35(15):1746-1747. PMID: 28524778.
    Citations:    Fields:    
  17. Shields H, Li J, Pelletier S, Wang H, Freedman R, Mamon H, Ng A, Freedman A, Come S, Avigan D, Huberman M, Recht A. Persistence of dysphagia and odynophagia after mediastinal radiation and chemotherapy in patients with lung cancer or lymphoma. Dis Esophagus. 2017 02 01; 30(2):1-8. PMID: 27247116.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  18. Mouw KW, Cleary JM, Reardon B, Pike J, Braunstein LZ, Kim J, Amin-Mansour A, Miao D, Damish A, Chin J, Ott PA, Fuchs CS, Martin NE, Getz G, Carter S, Mamon HJ, Hornick JL, Van Allen EM, D'Andrea AD. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma. Clin Cancer Res. 2017 Jun 15; 23(12):3214-3222. PMID: 27852700.
    Citations: 2     Fields:    Translation:Humans
  19. Rose BS, Winer EP, Mamon HJ. Perils of the Pathologic Complete Response. J Clin Oncol. 2016 11 20; 34(33):3959-3962. PMID: 27551115.
    Citations: 4     Fields:    Translation:Humans
  20. Song C, Liu Y, Fontana R, Makrigiorgos A, Mamon H, Kulke MH, Makrigiorgos GM. Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment. Nucleic Acids Res. 2016 Nov 02; 44(19):e146. PMID: 27431322.
    Citations: 9     Fields:    Translation:Humans
  21. Cleary JM, Mamon HJ, Szymonifka J, Bueno R, Choi N, Donahue DM, Fidias PM, Gaissert HA, Jaklitsch MT, Kulke MH, Lynch TP, Mentzer SJ, Meyerhardt JA, Swanson RS, Wain J, Fuchs CS, Enzinger PC. Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer. BMC Cancer. 2016 07 13; 16:468. PMID: 27412386.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  22. Schoenfeld JD, Wo JY, Mamon HJ, Kwak EL, Mullen JT, Enzinger PZ, Blaskowsky LS, Ryan DP, Hong TS. The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation. Am J Clin Oncol. 2016 06; 39(3):243-7. PMID: 24577163.
    Citations: 1     Fields:    Translation:Humans
  23. Yip SS, Coroller TP, Sanford NN, Mamon H, Aerts HJ, Berbeco RI. Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients. Front Oncol. 2016; 6:72. PMID: 27066454.
    Citations: 9     
  24. Yip SS, Coroller TP, Sanford NN, Huynh E, Mamon H, Aerts HJ, Berbeco RI. Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction. Phys Med Biol. 2016 Jan 21; 61(2):906-22. PMID: 26738433.
    Citations: 8     Fields:    Translation:Humans
  25. Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS, Kwak EL, Allen JN, Clark JW, Goyal L, Murphy JE, Javle MM, Wolfgang JA, Drapek LC, Arellano RS, Mamon HJ, Mullen JT, Yoon SS, Tanabe KK, Ferrone CR, Ryan DP, DeLaney TF, Crane CH, Zhu AX. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. J Clin Oncol. 2016 Feb 10; 34(5):460-8. PMID: 26668346.
    Citations: 34     Fields:    Translation:HumansCTClinical Trials
  26. Matalon SA, Mamon HJ, Fuchs CS, Doyle LA, Tirumani SH, Ramaiya NH, Rosenthal MH. Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy. Radiographics. 2015 Nov-Dec; 35(7):2090-107. PMID: 26562239.
    Citations: 2     Fields:    Translation:HumansCells
  27. Buscariollo DL, Mamon HJ. Optimal management of resectable gastric adenocarcinoma. Expert Rev Anticancer Ther. 2015; 15(8):931-41. PMID: 26165449.
    Citations: 2     Fields:    Translation:Humans
  28. Spector R, Zheng Y, Yeap BY, Wee JO, Lebenthal A, Swanson SJ, Marchosky DE, Enzinger PC, Mamon HJ, Lerut A, Odze R, Srivastava A, Agoston AT, Tippayawang M, Bueno R. The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation. Semin Thorac Cardiovasc Surg. 2015; 27(2):205-15. PMID: 26686448.
    Citations: 3     Fields:    Translation:Humans
  29. Yip S, Coroller T, Niu N, Mamon H, Aerts H, Berbeco R. TU-AB-BRA-12: Impact of Image Registration Algorithms On the Prediction of Pathological Response with Radiomic Textures. Med Phys. 2015 Jun; 42(6):3589. PMID: 26128817.
    Citations:    
  30. Wu AJ, Bosch WR, Chang DT, Hong TS, Jabbour SK, Kleinberg LR, Mamon HJ, Thomas CR, Goodman KA. Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. Int J Radiat Oncol Biol Phys. 2015 Jul 15; 92(4):911-20. PMID: 26104943.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  31. Castellanos-Rizaldos E, Paweletz C, Song C, Oxnard GR, Mamon H, Jänne PA, Makrigiorgos GM. Enhanced ratio of signals enables digital mutation scanning for rare allele detection. J Mol Diagn. 2015 May; 17(3):284-92. PMID: 25772705.
    Citations: 4     Fields:    Translation:HumansCells
  32. Steingisser L, Acker B, Berman S, Brenner MJ, Bornstein BA, Busse P, FitzGerald TJ, Jacobson JO, Jekowsky E, Kachnic LA, Mamon H, McKee A, Shulman LN, Stevenson MA, Wazer D, Fallon JA. Bending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology. J Oncol Pract. 2014 Sep; 10(5):e321-7. PMID: 25232190.
    Citations: 3     Fields:    Translation:Humans
  33. Mamon HJ, Tepper JE. Reply to E. C. Smyth et al. J Clin Oncol. 2014 Sep 20; 32(27):3082. PMID: 25071102.
    Citations:    Fields:    Translation:Humans
  34. Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock MG, Cheng JC, Feng MU, Stephans KL, Roberge D, Crane C, Dawson LA. Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):804-13. PMID: 24969794.
    Citations: 8     Fields:    Translation:Humans
  35. Hong TS, Ryan DP, Borger DR, Blaszkowsky LS, Yeap BY, Ancukiewicz M, Deshpande V, Shinagare S, Wo JY, Boucher Y, Wadlow RC, Kwak EL, Allen JN, Clark JW, Zhu AX, Ferrone CR, Mamon HJ, Adams J, Winrich B, Grillo T, Jain RK, DeLaney TF, Fernandez-del Castillo C, Duda DG. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):830-8. PMID: 24867540.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  36. Wolpin BM, Rubinson DA, Wang X, Chan JA, Cleary JM, Enzinger PC, Fuchs CS, McCleary NJ, Meyerhardt JA, Ng K, Schrag D, Sikora AL, Spicer BA, Killion L, Mamon H, Kimmelman AC. Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Oncologist. 2014 Jun; 19(6):637-8. PMID: 24821822.
    Citations: 56     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
  37. Patel SA, Chen YH, Hornick JL, Catalano P, Nowak JA, Zukerberg LR, Bleday R, Shellito PC, Hong TS, Mamon HJ. Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. Dis Colon Rectum. 2014 Apr; 57(4):449-59. PMID: 24608301.
    Citations: 7     Fields:    Translation:Humans
  38. Russo AL, Ryan DP, Borger DR, Wo JY, Szymonifka J, Liang WY, Kwak EL, Blaszkowsky LS, Clark JW, Allen JN, Zhu AX, Berger DL, Cusack JC, Mamon HJ, Haigis KM, Hong TS. Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer. J Gastrointest Cancer. 2014 Mar; 45(1):34-9. PMID: 24006244.
    Citations: 9     Fields:    Translation:Humans
  39. Mamon HJ, Tepper JE. Combination chemoradiation therapy: the whole is more than the sum of the parts. J Clin Oncol. 2014 Feb 10; 32(5):367-9. PMID: 24419110.
    Citations: 3     Fields:    Translation:Humans
  40. Blaszkowsky LS, Ryan DP, Szymonifka J, Borger DR, Zhu AX, Clark JW, Kwak EL, Mamon HJ, Allen JN, Vasudev E, Shellito PC, Cusack JC, Berger DL, Hong TS. Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer. Ann Oncol. 2014 Jan; 25(1):121-6. PMID: 24356623.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  41. Hong TS, DeLaney TF, Mamon HJ, Willett CG, Yeap BY, Niemierko A, Wolfgang JA, Lu HM, Adams J, Weyman EA, Arellano RS, Blaszkowsky LS, Allen JN, Tanabe KK, Ryan DP, Zhu AX. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. Pract Radiat Oncol. 2014 Sep-Oct; 4(5):316-322. PMID: 25194100.
    Citations: 9     Fields:    Translation:Humans
  42. Tseng YD, Krishnan MS, Jones JA, Sullivan AJ, Gorman D, Taylor A, Pacold M, Kalinowski B, Mamon HJ, Abrahm J, Balboni TA. Supportive and palliative radiation oncology service: impact of a dedicated service on palliative cancer care. Pract Radiat Oncol. 2014 Jul-Aug; 4(4):247-53. PMID: 25012833.
    Citations: 2     Fields:    Translation:Humans
  43. Wo JY, Mamon HJ, Ferrone CR, Ryan DP, Blaszkowsky LS, Kwak EL, Tseng YD, Napolitano BN, Ancukiewicz M, Swanson RS, Lillemoe KD, Fernandez-del Castillo C, Hong TS. Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer. Radiother Oncol. 2014 Jan; 110(1):160-4. PMID: 24231241.
    Citations: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  44. Wo JY, Childs SK, Szymonifka J, Mamon HJ, Ryan DP, Blaszkowsky LS, Kwak EL, Ferrone CR, Allen JN, Zhu AX, Wolpin BM, Chan JA, Abrams TA, McCleary NJ, Fernandez-Del Castillo C, Hong TS. Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):e117-e123. PMID: 24890357.
    Citations: 1     Fields:    Translation:Humans
  45. Jabbour SK, Hashem SA, Bosch W, Kim TK, Finkelstein SE, Anderson BM, Ben-Josef E, Crane CH, Goodman KA, Haddock MG, Herman JM, Hong TS, Kachnic LA, Mamon HJ, Pantarotto JR, Dawson LA. Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):82-89. PMID: 24890348.
    Citations: 15     Fields:    Translation:Humans
  46. Shulman LN, Mamon H, Jacobson JO, Steingisser L, Dodek A, Fallon JA. Partnership between a cancer center and payer: opportunities for improved quality of care and cost reduction. J Oncol Pract. 2013 May; 9(3):133-4. PMID: 23942490.
    Citations:    Fields:    Translation:Humans
  47. Pretz JL, Wo JY, Mamon HJ, Kachnic LA, Hong TS. Chemoradiation therapy: localized esophageal, gastric, and pancreatic cancer. Surg Oncol Clin N Am. 2013 Jul; 22(3):511-24. PMID: 23622077.
    Citations: 4     Fields:    Translation:Humans
  48. Lee MS, Mamon HJ, Hong TS, Choi NC, Fidias PM, Kwak EL, Meyerhardt JA, Ryan DP, Bueno R, Donahue DM, Jaklitsch MT, Lanuti M, Rattner DW, Fuchs CS, Enzinger PC. Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancer. Oncologist. 2013; 18(3):281-7. PMID: 23429739.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  49. Guha M, Castellanos-Rizaldos E, Liu P, Mamon H, Makrigiorgos GM. Differential strand separation at critical temperature: a minimally disruptive enrichment method for low-abundance unknown DNA mutations. Nucleic Acids Res. 2013 Feb 01; 41(3):e50. PMID: 23258702.
    Citations: 9     Fields:    Translation:HumansCells
  50. Castellanos-Rizaldos E, Liu P, Milbury CA, Guha M, Brisci A, Cremonesi L, Ferrari M, Mamon H, Makrigiorgos GM. Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment. Clin Chem. 2012 Jul; 58(7):1130-8. PMID: 22587896.
    Citations: 7     Fields:    Translation:HumansCells
  51. Wo JY, Yoon SS, Guimaraes AR, Wolfgang J, Mamon HJ, Hong TS. Gastric lymph node contouring atlas: A tool to aid in clinical target volume definition in 3-dimensional treatment planning for gastric cancer. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):e11-e19. PMID: 24674268.
    Citations: 3     Fields:    
  52. Mamon HJ. Long-term follow-up of a paradigm-changing study: the paradigm still holds. J Clin Oncol. 2012 Jun 01; 30(16):1901-3. PMID: 22529256.
    Citations: 1     Fields:    Translation:Humans
  53. Elnahal SM, Shinagare AB, Szymonifka J, Hong TS, Enzinger PC, Mamon HJ. Prevalence and significance of subcentimeter hepatic lesions in patients with localized pancreatic adenocarcinoma. Pract Radiat Oncol. 2012 Oct-Dec; 2(4):e89-e94. PMID: 24674191.
    Citations: 1     Fields:    
  54. Chen RC, Mamon HJ, Ancukiewicz M, Killoran JH, Crowley EM, Blaszkowsky LS, Wo JY, Ryan DP, Hong TS. Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e513-7. PMID: 22436781.
    Citations: 7     Fields:    Translation:Humans
  55. Wo JY, Mamon HJ, Ryan DP, Hong TS. T3N0 rectal cancer: radiation for all? Semin Radiat Oncol. 2011 Jul; 21(3):212-9. PMID: 21645866.
    Citations: 8     Fields:    Translation:Humans
  56. Hoffman KE, Neville BA, Mamon HJ, Kachnic LA, Katz MS, Earle CC, Punglia RS. Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer. 2012 Jan 01; 118(1):248-57. PMID: 21692071.
    Citations: 8     Fields:    Translation:Humans
  57. Fuchs CS, Tepper JE, Niedzwiecki D, Hollis D, Mamon HJ, Swanson R, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Enzinger PC, Goldberg RM, Venook AP, Mayer RJ. Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101. J Clin Oncol. 2011 May 20; 29(15_suppl):4003. PMID: 28020574.
    Citations:    
  58. Hong TS, Ryan DP, Blaszkowsky LS, Mamon HJ, Berger D, Fernandez-Del Castillo C, Zhu AX. A prospective study of capecitabine (cape), oxaliplatin (ox), bevacizumab (B), and radiation therapy (RT) (CAPOX-B RT) in patients with locally advanced or R1 biliary cancers: High risk of liver failure with extended hepatectomy. J Clin Oncol. 2011 May 20; 29(15_suppl):e14593. PMID: 28020501.
    Citations:    
  59. Margalit DN, Mamon HJ, Ancukiewicz M, Kobayashi W, Ryan DP, Blaszkowsky LS, Clark J, Willett CG, Hong TS. Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):e735-41. PMID: 21377289.
    Citations: 14     Fields:    Translation:Humans
  60. Milbury CA, Chen CC, Mamon H, Liu P, Santagata S, Makrigiorgos GM. Multiplex amplification coupled with COLD-PCR and high resolution melting enables identification of low-abundance mutations in cancer samples with low DNA content. J Mol Diagn. 2011 Mar; 13(2):220-32. PMID: 21354058.
    Citations: 10     Fields:    Translation:HumansCells
  61. Schoenfeld JD, Mamon HJ, Blaszkowsky LS, Enzinger PC, Wo JY, Allen JN, Wadlow RC, Ryan DP, Hong TS. Gastric adenocarcinoma treated with radiation with or without epirubicin-based chemotherapy: Evaluation of radiation-induced liver disease. J Clin Oncol. 2011 Feb; 29(4_suppl):110. PMID: 27985444.
    Citations:    
  62. Hong TS, Mamon H. Short-course versus standard chemoradiation in T3 rectal cancer. Oncologist. 2011; 16(5):717-21. PMID: 21586661.
    Citations:    Fields:    Translation:Humans
  63. Mamon HJ, Niedzwiecki D, Hollis D, Tan BR, Mayer RJ, Tepper JE, Goldberg RM, Blackstock AW, Fuchs CS. A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003. Cancer. 2011 Jun 15; 117(12):2620-8. PMID: 21656739.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  64. Bunnell CA, Weingart SN, Swanson S, Mamon HJ, Shulman LN. Models of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center. J Oncol Pract. 2010 Nov; 6(6):283-8. PMID: 21358956.
    Citations: 6     Fields:    
  65. Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a Surveillance, Epidemiology, and End Results Patterns-of-Care Study. Int J Radiat Oncol Biol Phys. 2011 Jul 15; 80(4):978-84. PMID: 20961695.
    Citations: 7     Fields:    Translation:Humans
  66. Arvold ND, Niemierko A, Mamon HJ, Fernandez-del Castillo C, Hong TS. Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1383-90. PMID: 20708856.
    Citations: 12     Fields:    Translation:Humans
  67. Hong TS, Ryan DP, Blaszkowsky LS, Mamon HJ, Kwak EL, Mino-Kenudson M, Adams J, Yeap B, Winrich B, DeLaney TF, Fernandez-Del Castillo C. Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):151-7. PMID: 20421151.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  68. Chen RC, Mamon HJ, Chen YH, Gelman RS, Suh WW, Talcott JA, Clark JW, Hong TS. Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer. Cancer. 2010 Apr 15; 116(8):1879-86. PMID: 20166212.
    Citations: 7     Fields:    Translation:Humans
  69. Park SJ, Ionascu D, Hacker F, Mamon H, Berbeco R. Automatic marker detection and 3D position reconstruction using cine EPID images for SBRT verification. Med Phys. 2009 Oct; 36(10):4536-46. PMID: 19928085.
    Citations: 12     Fields:    Translation:Humans
  70. Miyamoto DT, Mamon HJ, Ryan DP, Willett CG, Ancukiewicz M, Kobayashi WK, Blaszkowsky L, Fernandez-del Castillo C, Hong TS. Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older. Int J Radiat Oncol Biol Phys. 2010 Jul 15; 77(4):1171-7. PMID: 19800182.
    Citations: 11     Fields:    Translation:Humans
  71. Mak RH, Mamon HJ, Ryan DP, Miyamoto DT, Ancukiewicz M, Kobayashi WK, Willett CG, Choi NC, Blaszkowsky LS, Hong TS. Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older. Dis Esophagus. 2010 May; 23(4):316-23. PMID: 19788436.
    Citations: 11     Fields:    Translation:Humans
  72. Hattangadi JA, Hong TS, Yeap BY, Mamon HJ. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma. Cancer. 2009 Aug 15; 115(16):3640-50. PMID: 19514088.
    Citations: 20     Fields:    Translation:Humans
  73. Hong T, Ryan DP, Blaszkowsky LS, Mamon HJ, Mino-Kenudson M, Adams J, Yeap B, Winrich B, DeLaney TF, Fernandez-Del Castillo C. Phase I study of preoperative (pre-op) short course chemoradiation (CRT) with proton beam therapy (PBT) and capecitabine (cape) for resectable pancreatic ductal adenocarcinoma (PDAC) of the head. J Clin Oncol. 2009 May 20; 27(15_suppl):e15536. PMID: 27962312.
    Citations:    
  74. Blaszkowsky LS, Hong TS, Zhu AX, Kwak EL, Mamon HJ, Shellito PC, Cusack JC, Berger D, Horgan K, Ryan DP. A phase I/II study of bevacizumab (beva), erlotinib (erl), and 5-fluorouracil (5-FU) with concurrent external beam radiation therapy (RT) in locally advanced rectal cancer (LARC). J Clin Oncol. 2009 May 20; 27(15_suppl):4106. PMID: 27961180.
    Citations:    
  75. Hong TS, Killoran JH, Mamede M, Mamon HJ. Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1612-8. PMID: 19028285.
    Citations: 7     Fields:    Translation:Humans
  76. Nanda A, Mamon HJ, Fuchs CS. Sign of Leser-Trélat in newly diagnosed advanced gastric adenocarcinoma. J Clin Oncol. 2008 Oct 20; 26(30):4992-3. PMID: 18809604.
    Citations: 2     Fields:    Translation:Humans
  77. Mamon H, Hader C, Li J, Wang L, Kulke M, Amicarelli G, Shehi E, Adlerstein D, Roper K, Killion L, Hooshmand S, Makrigiorgos GM. Preferential amplification of apoptotic DNA from plasma: potential for enhancing detection of minor DNA alterations in circulating DNA. Clin Chem. 2008 Sep; 54(9):1582-4. PMID: 18755913.
    Citations: 6     Fields:    Translation:Humans
  78. Berbeco RI, Hacker F, Zatwarnicki C, Park SJ, Ionascu D, O'Farrell D, Mamon HJ. A novel method for estimating SBRT delivered dose with beam's-eye-view images. Med Phys. 2008 Jul; 35(7):3225-31. PMID: 18697547.
    Citations: 4     Fields:    Translation:Humans
  79. Berbeco RI, Hacker F, Zatwarnicki C, Park SJ, Ionascu D, O'Farrell D, Mamon HJ. A novel method for estimating SBRT delivered dose with beam's-eye-view images. Med Phys. 2008 Jul; 35(7Part1):3225-3231. PMID: 28513022.
    Citations:    
  80. Li J, Wang L, Mamon H, Kulke MH, Berbeco R, Makrigiorgos GM. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med. 2008 May; 14(5):579-84. PMID: 18408729.
    Citations: 89     Fields:    Translation:HumansCells
  81. Lyatskaya Y, James S, Killoran JH, Soto R, Mamon HJ, Chin L, Allen AM. Infrared-guided patient setup for lung cancer patients. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1124-33. PMID: 18249503.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  82. Berbeco R, Hacker F, Zatwarnicki C, Ionascu D, Park S-J. Mamon H. Volume 69, Issue 3 (Supplement 1) , S654. . Image-guided SBRT Dose Delivery Assessment: A Feasibility Study. International Journal of Radiation Oncology, Biology, Physics. 2007; 69(3):S654.
  83. Berbeco RI, Hacker F, Ionascu D, Mamon HJ. Clinical feasibility of using an EPID in CINE mode for image-guided verification of stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):258-66. PMID: 17707280.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  84. Wang F, Wang L, Briggs C, Sicinska E, Gaston SM, Mamon H, Kulke MH, Zamponi R, Loda M, Maher E, Ogino S, Fuchs CS, Li J, Hader C, Makrigiorgos GM. DNA degradation test predicts success in whole-genome amplification from diverse clinical samples. J Mol Diagn. 2007 Sep; 9(4):441-51. PMID: 17690213.
    Citations: 17     Fields:    Translation:HumansCells
  85. Mamon H, Willett CG. Is radiation therapy required for patients with intermediate-risk rectal cancer? Clin Adv Hematol Oncol. 2007 Aug; 5(8):638-44, 585. PMID: 17982404.
    Citations:    Fields:    Translation:Humans
  86. Mamede M, Abreu-E-Lima P, Oliva MR, Nosé V, Mamon H, Gerbaudo VH. FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results. Am J Clin Oncol. 2007 Aug; 30(4):377-88. PMID: 17762438.
    Citations: 21     Fields:    Translation:Humans
  87. Kozak KR, Kachnic LA, Adams J, Crowley EM, Alexander BM, Mamon HJ, Fernandez-Del Castillo C, Ryan DP, DeLaney TF, Hong TS. Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1557-66. PMID: 17544599.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  88. Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ. Adjuvant treatment of colorectal cancer. CA Cancer J Clin. 2007 May-Jun; 57(3):168-85. PMID: 17507442.
    Citations: 75     Fields:    Translation:Humans
  89. Balboni TA, Gaccione P, Gobezie R, Mamon HJ. Shielding of the hip prosthesis during radiation therapy for heterotopic ossification is associated with increased failure of prophylaxis. Int J Radiat Oncol Biol Phys. 2007 Apr 01; 67(5):1499-505. PMID: 17234358.
    Citations: 4     Fields:    Translation:Humans
  90. Hong TS, Crowley EM, Killoran J, Mamon HJ. Considerations in treatment planning for esophageal cancer. Semin Radiat Oncol. 2007 Jan; 17(1):53-61. PMID: 17185198.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  91. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65(5):1289-99. PMID: 16863921.
    Citations: 57     Fields:    Translation:Humans
  92. Enzinger PC, Yock T, Suh W, Fidias P, Mamon H, Choi N, Lehman N, Lawrence C, Lynch T, Fuchs C. Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):4064. PMID: 27953592.
    Citations:    
  93. Li J, Wang F, Mamon H, Kulke MH, Harris L, Maher E, Wang L, Makrigiorgos GM. Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples. Clin Chem. 2006 Apr; 52(4):624-33. PMID: 16469859.
    Citations: 12     Fields:    Translation:Humans
  94. Li J, Harris L, Mamon H, Kulke MH, Liu WH, Zhu P, Mike Makrigiorgos G. Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma. J Mol Diagn. 2006 Feb; 8(1):22-30. PMID: 16436631.
    Citations: 12     Fields:    Translation:HumansCells
  95. Chen AB, Killoran J, Kim H, Mamon H. Treatment planning for resected abdominal tumors: differences in organ position between diagnostic and radiation-planning computed tomography scans. Int J Radiat Oncol Biol Phys. 2005 Dec 01; 63(5):1613-20. PMID: 16115738.
    Citations:    Fields:    Translation:Humans
  96. Mamon HJ, Yeap BY, Jänne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH, Berman S, Skarin A, Bueno R. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005 Mar 01; 23(7):1530-7. PMID: 15735128.
    Citations: 38     Fields:    Translation:Humans
  97. Mamon HJ, Yeap B, Reblando J, Shrager S, Jaklitsch MT, Lukanich JM, Sugarbaker DJ, Baldini E, Janne P, Bueno R. High risk of brain metastases in surgically staged IIIA NSCLC patients treated with surgery, chemotherapy and radiation. J Clin Oncol. 2004 Jul 15; 22(14_suppl):7173. PMID: 28014275.
    Citations:    
  98. Aitken C, Breen E, Mamon HJ. Sphincter preservation therapy for rectal cancer. Clin Adv Hematol Oncol. 2003 Dec; 1(12):735-40. PMID: 16258478.
    Citations:    Fields:    Translation:Humans
  99. Mamon HJ, Dahlberg W, Azzam EI, Nagasawa H, Muto MG, Little JB. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation. Int J Radiat Biol. 2003 Oct; 79(10):817-29. PMID: 14630541.
    Citations: 2     Fields:    Translation:HumansCells
  100. Wenz F, Mamon H. Perioperative radiotherapy for cancer of the esophagus. Sem. Surg. Onc. 2001; 20:33-39.
  101. Mamon H, Willett C. Radiotherapy for Rectal Cancer: the European and US Approach. Colorectal Cancer: A Clinical Guide to Therapy. 2001; 239-248.
  102. Wenz F, Mamon H. Perioperative radiotherapy for cancer of the esophagus. Semin Surg Oncol. 2001 Jan-Feb; 20(1):33-9. PMID: 11291130.
    Citations:    Fields:    Translation:Humans
  103. Mamon HJ, Wen PY, Burns AC, Loeffler JS. Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia. 1999 Mar; 40(3):341-4. PMID: 10080516.
    Citations: 16     Fields:    Translation:Humans
  104. Fu H, Xia K, Pallas DC, Cui C, Conroy K, Narsimhan RP, Mamon H, Collier RJ, Roberts TM. Interaction of the protein kinase Raf-1 with 14-3-3 proteins. Science. 1994 Oct 07; 266(5182):126-9. PMID: 7939632.
    Citations: 59     Fields:    Translation:HumansAnimalsCells
  105. Montross L, Watkins S, Moreland RB, Mamon H, Caspar DL, Garcea RL. Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1. J Virol. 1991 Sep; 65(9):4991-8. PMID: 1651418.
    Citations: 33     Fields:    Translation:AnimalsCells
  106. Zmuidzinas A, Mamon HJ, Roberts TM, Smith KA. Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CD3-stimulated primary human T cells. Mol Cell Biol. 1991 May; 11(5):2794-803. PMID: 1708096.
    Citations: 22     Fields:    Translation:HumansCells
  107. Li P, Wood K, Mamon H, Haser W, Roberts T. Raf-1: a kinase currently without a cause but not lacking in effects. Cell. 1991 Feb 08; 64(3):479-82. PMID: 1846778.
    Citations: 41     Fields:    Translation:AnimalsCells
  108. Kanakura Y, Druker B, Wood KW, Mamon HJ, Okuda K, Roberts TM, Griffin JD. Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce rapid phosphorylation and activation of the proto-oncogene Raf-1 in a human factor-dependent myeloid cell line. Blood. 1991 Jan 15; 77(2):243-8. PMID: 1845931.
    Citations: 20     Fields:    Translation:HumansCells
  109. Mamon H, Williams N, Wood K, Frazier AL, Li P, Zmuidzinas A, Kremer N, D'Acangelo G, Qi H, Smith K, et al. New perspectives on Raf-1: the involvement of p21ras in the activation of Raf-1 and a potential role for Raf-1 in events occurring later in the cell cycle. Cold Spring Harb Symp Quant Biol. 1991; 56:251-63. PMID: 1819489.
    Citations:    Fields:    Translation:HumansAnimalsCells
  110. Druker BJ, Mamon HJ, Roberts TM. Oncogenes, growth factors, and signal transduction. N Engl J Med. 1989 Nov 16; 321(20):1383-91. PMID: 2682241.
    Citations: 71     Fields:    Translation:HumansCells
  111. Roberts TM, Kaplan D, Morgan W, Keller T, Mamon H, Piwnica-Worms H, Druker B, Cohen B, Schaffhausen B, Whitman M, et al. Tyrosine phosphorylation in signal transduction. Cold Spring Harb Symp Quant Biol. 1988; 53 Pt 1:161-71. PMID: 2855480.
    Citations: 2     Fields:    Translation:AnimalsCells
  112. Bikel I, Mamon H, Brown EL, Boltax J, Agha M, Livingston DM. The t-unique coding domain is important to the transformation maintenance function of the simian virus 40 small t antigen. Mol Cell Biol. 1986 Apr; 6(4):1172-8. PMID: 3023875.
    Citations: 19     Fields:    Translation:Cells
  113. Bikel I, Mamon H, Brown EL, Boltax J, Agha M, Livingston DM. The role of small t antigen in the simian virus 40 transforming mechanism. Cancer Cells. 1986; 4:405-12.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mamon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (411)
Explore
_
Co-Authors (142)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.